Luce Emerson

Luce Emerson

Luce Emerson is a former sell-side banker with a broad range of capital markets experience. She continues to follow markets closely, with a particular focus on retail, financials and entertainment.

Recent Articles

Chemicals Growth, Investments Helping to Boost Exxon Mobil Stock

With oil rallying over the past month, it makes sense to revisit Exxon Mobil stock. XOM stock is up 10% on exploration, chemicals push.

Legal Risk Weighs on Johnson & Johnson Stock

This year, JNJ stock has appreciated just 11%, compared to over 17% for the Dow, as legal risks continue to weigh on the stock.

Why Starbucks Stock Will Continue to Brew Profits for Investors

There is good reason to be bullish on Starbucks stock. SBUX stock finished 2018 strong, and that momentum has continued into 2019.

With Pinterest and Uber, IPO Investing Just Got a Little Trickier

Investing in IPOs is not like it used to be. More and more companies are going public without any earnings, defying traditional valuation methods. Buy and hold without proper analysis is no longer a sure bet on generating alpha. That said, buy Uber sell Pinterest.

Intuitive Surgical Stock Is the Best MedTech Company to Buy and Hold

ISRG stock has started off 2019 in great fashion with back-to-back FDA approvals. ISRG's momentum should continue.

Pepsico Stock Is Fizzing Ahead of Earnings

After Ramón Laguarta stepped in as PEP CEO, the market has rallied behind him. In the past 3 months, Pepsico stock is up 12%.

Lyft Stock Is the Best Vehicle to Play the Future of Transportation  

With all the headlines focusing on the almost billion-dollar loss of LYFT, investors may have glossed over a potentially huge opportunity for LYFT stock.

3 Sin Stocks to Double Down On

While sin stocks are traditionally thought of as a recessionary hedge, these three stocks will exceed your expectations.

Roku Stock Has A Target On Its Back As Apple Revs Up Its TV Engine

Roku stock has taken a tumble over the past month, down close to 20%, driven by a series of downgrades by the likes of Guggenheim, Macquarie, and Citigroup.  

Here’s the Real Problem with Altria Overpaying for CRON Stock

Altria Group Inc (NYSE:MO) was the latest in a frenzied string of M&A and partnerships in the cannabis sector. Marijuana stocks have been the target of billion-dollar investments, and the $102 billion market cap company and owner of veteran cigarette brands Marlboro, Parliament, and Virginia Slims, last month that it was investing approximately $1.8 billion in Canadian-based Cronos Group Inc (NASDAQ:CRON), which is listed both on the TSX as well as the NASDAQ.